Month: June 2021

Arbutus Biopharma and Antios Therapeutics Announce Clinical Collaboration Agreement to Evaluate AB-729 in Combination with ATI-2173 in Subjects with Chronic Hepatitis B Virus Infection

MENDHAM, N.J. and WARMINSTER, Pa., June 29, 2021 (GLOBE NEWSWIRE) -- Antios Therapeutics, Inc. and Arbutus Biopharma Corporation (Nasdaq: ABUS)...

Surescripts Clinical Direct Messaging Closes the Data Gap Between Care Providers in Support of Nationwide COVID-19 Vaccination Effort

Interoperable Health Information Technology Enables Secure Information Sharing Between Pharmacies and Primary Care Providers ARLINGTON, Va.--(BUSINESS WIRE)--#COVID19--With pharmacies playing a...

Babson Diagnostics Raises $31 Million in Series B Funding to Drive Retailization of Customer-First, Convenient, and Highly Accessible Diagnostic Blood Testing

Funding Marks Latest Milestone on Path to Commercialization AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics, a transformative medical technology company improving customer access...

Defence Therapeutics Signs a Collaboration Agreement with the Curie Institute for Testing the Accum-T-DM1 ADC Therapeutic in PDX Models of Breast Cancer

Vancouver, British Columbia--(Newsfile Corp. - June 29, 2021) - Defence Therapeutics Inc. (CSE: DTC) ("Defence" or the "Company"), is pleased...

error: Content is protected !!